Ghent University Academic Bibliography

Your filters: cql: author="Westermann, Frank" or (type any "bookEditor journalEditor issueEditor" and editor="Wester...

Add to list
- Journal Article
- A1
- open access
Ferroptosis in health and disease

Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, Scott Ayton, Uladzimir Barayeu, Alexander Bartelt, Hülya Bayir, Christina M Bebber, Kivanc Birsoy, Jan P Böttcher, et al.

(2024) REDOX BIOLOGY. 75.
Add to list
- Journal Article
- A1
- open access
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F. Gerloff, Sonja Herter, Petra Fiesel, Yannick Berker, Mirjam Blattner-Johnson, Kathrin Schramm, Barbara C. Jones, et al.

(2022) NPJ PRECISION ONCOLOGY. 6(1).
Add to list
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

Elena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, Bieke Decaesteker (UGent) , Geertrui Denecker (UGent) , Gregor Mönke, Umut H Toprak, Andres Florez, Alica Torkov, Daniel Dreidax, et al.

(2021) LIFE SCIENCE ALLIANCE. 4(5).
Add to list
- Conference Paper
- C3
SOX11 as guardian of epigenetic plasticity in neuroblastoma

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Siebe Loontiens (UGent) , Sara De Brouwer, Carolina de Carvalho Nunes (UGent) , Geertrui Denecker (UGent) , Fanny De Vloed (UGent) , Lisa Depestel (UGent) , Juliette Roels (UGent) , Karen Verboom, et al.

(2021) Advances in Neuroblastoma Research (ANR 2021), Abstracts.
Add to list
ALK positively regulates MYCN activity through repression of HBP1 expression

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Kaat Durinck (UGent) , Bieke Decaesteker (UGent) , Liselot Mus (UGent) , Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.

(2019) ONCOGENE. 38(5). p.2690-2705
Add to list
- Conference Paper
- C3
SOX11 as mediator of the adrenergic cell state in NB

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Sara De Brouwer (UGent) , Volodimir Olexiouk (UGent) , Geertrui Denecker (UGent) , Carolina de Carvalho Nunes (UGent) , Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke (UGent) , Elena Afanasyeva, et al.

(2019) Pediatric Oncology and Hematology, 2nd KiTZ symposium, Abstracts.
Add to list
- Journal Article
- A1
- open access
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

Bieke Decaesteker (UGent) , Geertrui Denecker (UGent) , Christophe Van Neste (UGent) , Emmy M Dolman, Wouter Van Loocke (UGent) , Moritz Gartlgruber, Carolina de Carvalho Nunes (UGent) , Fanny De Vloed (UGent) , Pauline Depuydt, Karen Verboom, et al.

(2018) NATURE COMMUNICATIONS. 9.
Add to list
A mechanistic classification of clinical phenotypes in neuroblastoma.

Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke, et al.

(2018) SCIENCE. 362(6419). p.1165-1170
Add to list
- Conference Paper
- C3
BRD3 as a specific vulnerable therapeutic target in neuroblastoma

Jolien De Wyn, Kaat Durinck (UGent) , Anneleen Beckers, Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Daniel Carter, Belamy Chueng, Glenn Marshall, Katleen De Preter (UGent) , Frank Westermann, et al.

(2017) Protecting the Code : Epigenetic Impacts on Genome Stability, EACR conference, Abstracts.
Add to list
- Conference Paper
- C3
HBP1 is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Irina Lambertz (UGent) , Els Janssens (UGent) , Suzanne Vanhauwaert (UGent) , Bieke Decaesteker (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Kristina Althoff, et al.

(2017) Treatment and Research Center for Pediatric Oncology and Haematology Heidelberg, Opening symposium, Abstracts.

Academic Bibliography

Ferroptosis in health and disease

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

SOX11 as guardian of epigenetic plasticity in neuroblastoma

ALK positively regulates MYCN activity through repression of HBP1 expression

SOX11 as mediator of the adrenergic cell state in NB

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

A mechanistic classification of clinical phenotypes in neuroblastoma.

BRD3 as a specific vulnerable therapeutic target in neuroblastoma

HBP1 is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Contents

Support

Contact